Journal

Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research
ISSN: 1557-7465
Titre abrégé: J Interferon Cytokine Res
Pays: United States
ID NLM: 9507088

Informations de publication

Date de publication:
09 2023
Historique:
pmc-release: 01 09 2024
medline: 20 9 2023
pubmed: 27 6 2023
entrez: 27 6 2023
Statut: ppublish

Résumé

Interferon lambda 4 (IFN-λ4) is a novel type-III interferon that can be expressed only by carriers of the genetic variant rs368234815-dG within the first exon of the

Identifiants

pubmed: 37366802
doi: 10.1089/jir.2023.0014
pmc: PMC10623078
doi:

Substances chimiques

Interleukins 0
IFNL4 protein, human 0

Types de publication

Journal Article Research Support, N.I.H., Intramural Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

394-402

Subventions

Organisme : NCI NIH HHS
ID : HHSN261201100063C
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261201100007I
Pays : United States

Références

EBioMedicine. 2017 Nov;25:58-65
pubmed: 29033373
Nat Immunol. 2015 Aug;16(8):802-9
pubmed: 26194286
Front Cell Infect Microbiol. 2019 Oct 04;9:340
pubmed: 31637221
J Interferon Cytokine Res. 2014 Nov;34(11):829-38
pubmed: 24786669
Malar J. 2020 Jul 28;19(1):239
pubmed: 32718346
Infect Agent Cancer. 2014 Sep 11;9:32
pubmed: 25686906
Malar J. 2018 Jun 20;17(1):240
pubmed: 29925378
J Immunol. 2017 Dec 1;199(11):3808-3820
pubmed: 29070670
EMBO J. 2013 Nov 27;32(23):3055-65
pubmed: 24169568
Nat Immunol. 2003 Jan;4(1):69-77
pubmed: 12483210
J Infect Dis. 2014 Feb 1;209(3):350-4
pubmed: 23956438
Commun Biol. 2018 Nov 14;1:191
pubmed: 30456312
Leukemia. 2022 Jul;36(7):1720-1748
pubmed: 35732829
PLoS Pathog. 2014 May 29;10(5):e1004170
pubmed: 24874410
Am J Hum Genet. 2016 Apr 7;98(4):653-66
pubmed: 27018471
Lancet Haematol. 2020 Oct;7(10):e715-e723
pubmed: 32976751
Trop Med Int Health. 2019 May;24(5):571-585
pubmed: 30843638
AIDS Res Ther. 2020 Apr 15;17(1):13
pubmed: 32295609
Clin Infect Dis. 2023 Feb 8;76(3):521-527
pubmed: 36573283
Lancet. 1964 Mar 28;1(7335):702-3
pubmed: 14107961
Nat Rev Dis Primers. 2022 Dec 15;8(1):78
pubmed: 36522349
PLoS Pathog. 2018 Oct 11;14(10):e1007307
pubmed: 30308076
Nat Rev Immunol. 2015 Mar;15(3):172-84
pubmed: 25712152
Am J Trop Med Hyg. 2019 Jan;100(1):54-65
pubmed: 30457091
Int J Cancer. 2020 Feb 15;146(4):953-969
pubmed: 31054214
Nat Genet. 2013 Feb;45(2):164-71
pubmed: 23291588
PLoS One. 2008 Jun 18;3(6):e2505
pubmed: 18560562
PLoS Biol. 2020 Jan 17;18(1):e3000586
pubmed: 31951611
Malar J. 2017 Mar 20;16(1):124
pubmed: 28320389
AIDS. 2014 Aug 24;28(13):1885-9
pubmed: 25259701
Genes Immun. 2021 May;22(1):44-55
pubmed: 33850301
Malar J. 2021 Apr 21;20(1):196
pubmed: 33882912
PLoS Genet. 2014 Oct 16;10(10):e1004681
pubmed: 25329461
Cancers (Basel). 2021 Apr 02;13(7):
pubmed: 33918470
Prostate Cancer Prostatic Dis. 2023 Jun;26(2):338-346
pubmed: 35468990
J Interferon Cytokine Res. 2019 Oct;39(10):599-608
pubmed: 31070498
Nat Immunol. 2003 Jan;4(1):63-8
pubmed: 12469119
J Natl Cancer Inst. 1969 Jan;42(1):19-28
pubmed: 4303830
Nat Commun. 2014 Dec 23;5:5699
pubmed: 25534433

Auteurs

Francine S Baker (FS)

Laboratory of Translational Genomics, National Cancer Institute, Rockville, Maryland, USA.

Jeanny Wang (J)

Laboratory of Translational Genomics, National Cancer Institute, Rockville, Maryland, USA.

Oscar Florez-Vargas (O)

Laboratory of Translational Genomics, National Cancer Institute, Rockville, Maryland, USA.

Nathan R Brand (NR)

Department of Surgery, University of California, San Francisco, California, USA.

Martin D Ogwang (MD)

EMBLEM Study, St. Mary's Hospital, Lacor, Uganda.
EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.

Patrick Kerchan (P)

EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.
EMBLEM Study, Kuluva Hospital, Arua, Uganda.

Steven J Reynolds (SJ)

Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Constance N Tenge (CN)

EMBLEM Study, Moi University College of Health Sciences, Eldoret, Kenya.

Pamela A Were (PA)

EMBLEM Study, Academic Model Providing Access To Healthcare (AMPATH), Eldoret, Kenya.

Robert T Kuremu (RT)

EMBLEM Study, Moi University College of Health Sciences, Eldoret, Kenya.

Walter N Wekesa (WN)

EMBLEM Study, Moi University College of Health Sciences, Eldoret, Kenya.

Nestory Masalu (N)

EMBLEM Study, Bugando Medical Center, Mwanza, Tanzania.

Esther Kawira (E)

EMBLEM Study, Shirati Health, Education, and Development Foundation, Shirati, Tanzania.

Tobias Kinyera (T)

EMBLEM Study, St. Mary's Hospital, Lacor, Uganda.
EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.

Isaac Otim (I)

EMBLEM Study, St. Mary's Hospital, Lacor, Uganda.
EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.

Ismail D Legason (ID)

EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.
EMBLEM Study, Kuluva Hospital, Arua, Uganda.

Hadijah Nabalende (H)

EMBLEM Study, St. Mary's Hospital, Lacor, Uganda.
EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.

George Chagaluka (G)

Department of Pediatrics and Surgery, Kamuzu University of Health Sciences, Blantyre, Malawi.

Nora Mutalima (N)

Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, United Kingdom.
Cancer Epidemiology Unit, University of Oxford, Oxford, United Kingdom.

Eric Borgstein (E)

Department of Pediatrics and Surgery, Kamuzu University of Health Sciences, Blantyre, Malawi.

George N Liomba (GN)

Department of Pediatrics and Surgery, Kamuzu University of Health Sciences, Blantyre, Malawi.

Steve Kamiza (S)

Department of Pediatrics and Surgery, Kamuzu University of Health Sciences, Blantyre, Malawi.

Nyengo Mkandawire (N)

Department of Pediatrics and Surgery, Kamuzu University of Health Sciences, Blantyre, Malawi.

Collins Mitambo (C)

Research Department, Ministry of Health, Lilongwe, Malawi.

Elizabeth M Molyneux (EM)

Department of Pediatrics and Surgery, Kamuzu University of Health Sciences, Blantyre, Malawi.

Robert Newton (R)

Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, United Kingdom.

Ludmila Prokunina-Olsson (L)

Laboratory of Translational Genomics, National Cancer Institute, Rockville, Maryland, USA.

Sam M Mbulaiteye (SM)

Laboratory of Translational Genomics, National Cancer Institute, Rockville, Maryland, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH